AtriCure (ATRC) Reports In-Line Q2 EPS, provides guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to AtriCure (ATRC) Reports In-Line Q2 EPS, provides guidance

AtriCure Inc. (ATRC) PT Lowered to $53 at BTIG

July 31, 2024 4:58 AM EDT

BTIG analyst Marie Thibault lowered the price target on AtriCure Inc. (NASDAQ: ATRC) to $53.00 (from $58.00) while maintaining a Buy rating.

The analyst comments "AtriCure reported Q2 revenue of $116.3M (+15.2% y/y rep, +15.4% y/y cc), in line with consensus of $116.2M. U.S. Q2 revenue was $95.5M (+12.5% y/y), lower than consensus of $97.1M, while International revenue of $20.7M (+29.4% y/y rep, +30.4% y/y cc) beat consensus of $19.0M. The U.S. Appendage Management segment reported $37.9M (+11.8% y/y) in Q2 sales, missing consensus of $38.3M by $400K. However, growth in... More